Trial Profile
Chemoembolization With or Without Antiviral Therapy for Unresectable HBV-related Hepatocellular Carcinoma With Low HBV DNA Replication: Effectiveness and Safety. A Prospective and Randomized Clinical Trial
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Lamivudine (Primary) ; Antineoplastics
- Indications Hepatitis B; Liver cancer
- Focus Therapeutic Use
- 27 Aug 2013 New trial record